Home Markets Eli Lilly’s Zepbound outperforms Novo Nordisk’s Wegovy in weight loss trial

Eli Lilly’s Zepbound outperforms Novo Nordisk’s Wegovy in weight loss trial

Andrew M May 12, 2025 comments off

Original source: https://www.investing.com/news/stock-market-news/eli-lillys-zepbound-outperformsnovo-nordisks-wegovy-in-weight-loss-trial-4037781

Eli Lilly Market Updates Novo Nordisk www.investing.com/news/stock-market-news/eli-lillys-zepbound-outperformsnovo-nordisks-wegovy-in-weight-loss-trial-4037781